The Acronym Behind Our Wildest AI Dreams and Nightmares
By Émile P. Torres,
Truthdig
| 06. 15. 2023
TESCREAL—pronounced “tess-cree-all.” It’s a strange word that you may have seen pop up over the past few months. The renowned computer scientist Dr. Timnit Gebru frequently mentions the “TESCREAL” ideologies on social media, and for a while the Twitter profile of billionaire venture capitalist Marc Andreessen read: “cyberpunk activist; embracer of variance; TESCREAList.” The Financial Times, Business Insider and VentureBeat have all used or investigated the word. And The Washington Spectator published an article by Dave Troy titled, “Understanding TESCREAL—The Weird Ideologies Behind Silicon Valley’s Rightward Turn.”
My guess is that the acronym will gain more attention as the topic of artificial intelligence becomes more widely discussed, along with questions about the strange beliefs of its most powerful Silicon Valley proponents and critics. But what the heck does “TESCREAL” mean and why does it matter?
I have thought a lot about these questions, as I coined the term in an as-yet unpublished academic paper, co-written with Gebru, tracing the influence of a small constellation of interrelated and overlapping ideologies within the contemporary field of AI. Those ideologies, we believe, are...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...